Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)

Revenue

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
GSK Revenue	2.65M	Log In	Log In	Log In
Horizon Revenue	-	Log In	Log In	Log In
Takeda Revenue	-	Log In	Log In	Log In
Janssen Revenue	-	Log In	Log In	Log In
Amgen Revenue	-	Log In	Log In	Log In
Sarepta Revenue	696.80M	Log In	Log In	Log In
Sanofi Revenue	130.00M	Log In	Log In	Log In
Revenue (Total)	829.45M	Log In	Log In	Log In

Updated Sep 30, 2025. Data Source: Fiscal.ai.